Xerostomia is a severe side effect of radiation therapy in head and neck cancer patients. To date, no satisfactory treatment option has been established. Because mesenchymal stem cells (MSCs) have been identified as a potential treatment modality, we aimed to evaluate stem cell distribution following intravenous and intraglandular injections using a surgical model of salivary gland damage and to analyse the effects of MSC injections on the recruitment of immune cells. The submandibular gland ducts of rats were surgically ligated. Syngeneic adult MSCs were isolated, immortalised by simian virus 40 (SV40) large T antigen and characterized by flow cytometry. MSCs were injected intravenously and intraglandularly. After 1, 3 and 7 days, the organs of interest were analysed for stem cell recruitment. Inflammation was analysed by immunohistochemical staining. We were able to demonstrate that, after intravenous injection, MSCs were recruited to normal and damaged submandibular glands on days 1, 3 and 7. Unexpectedly, stem cells were recruited to ligated and non-ligated glands in a comparable manner. After intraglandular injection of MSCs into ligated glands, the presence of MSCs, leucocytes and macrophages was enhanced, compared to intravenous injection of stem cells. Our data suggest that injected MSCs were retained within the inflamed glands, could become activated and subsequently recruited leucocytes to the sites of tissue damage.
INTRODUCTION
One major cause of xerostomia in patients suffering from head and neck cancer is radiation therapy. Radiation therapy results in irreversible salivary gland tissue damage and loss of saliva. Without the lubricating and protecting functions of saliva, the oral cavity is highly susceptible to infections, including rampant caries and candidiasis, dysphagia, oral pain and discomfort. These complications result in a significantly reduced quality of life for these patients. Between 300 000 and 500 000 patients undergo radiation therapy each year worldwide, 1 and as a consequence, most of these patients will experience severe salivary gland hypofunction. Neither the prophylactic use of amifostine 2 to prevent radiation-induced xerostomia nor symptomatic treatment strategies, such as pilocarpine, have offered satisfactory relief from symptoms. Intensity-modulated radiation therapy holds great promise in reducing xerostomia; 3 however, it is neither available nor applicable in the majority of cancer patients. In summary, no effective therapy is yet available for salivary gland hypofunction.
The molecular mechanisms underlying acute radiation damage of the salivary glands are not fully understood. 4 However, it is clear that xerostomia results from acinar cell loss and the subsequent failure to replace these fluid-producing cells. 5 Recently, we demonstrated a baseline proliferative activity for all five cell types of the salivary glands, 6 suggesting that the salivary gland epithelium undergoes a continual level of basal regeneration. Although the exact mechanism of salivary gland regeneration has not been established, differentiation from a putative uncommitted stem cell population has long been favoured as a theory. 7 This stem cell population is believed to reside in the intercalated ducts because these cells are capable of repopulating both acinar and granular duct compartments. [8] [9] We were recently able to isolate mesenchymal stem cells (MSCs) from human parotid and submandibular glands. 10 Radiation-induced xerostomia is believed to be caused by the destruction of the stem cell reservoir in the salivary glands. Replacement of these stem cells by stem cell infusion could potentially allow for the resumption of salivary gland regeneration.
We previously demonstrated the regenerative potential of stem cells in an ischaemia-reperfusion model in mice by ligation of the femoral artery.
11 Importantly, this model did not require the ablation of bone marrow and thus actual transplantation of MSCs. Until now, a number of studies have demonstrated the beneficial effects of different types of stem cells (bone marrow-derived and salivary gland-derived) on salivary gland regeneration in animal models. [12] [13] [14] Comprehensive review articles have been published that detail the use of the different stem cell types. 15, 16 However, the exact mechanisms, as well as the physiological migration characteristics, remain largely unknown.
In this study, we sought to analyse stem cell distribution in a rodent model of salivary gland damage by comparing intravenous (i.v.) and intraglandular infusions of immortalised bone marrow-derived MSCs. Furthermore, we aimed to analyse the inflammatory responses following surgical duct ligation and stem cell administration to obtain greater knowledge of cellular MSC therapies.
MATERIALS AND METHODS
Cell isolation, propagation and immortalisation Syngeneic adult mesenchymal rat stem cells were isolated from the bone marrow of Wistar rats. The mononuclear cells were cultured in tissue culture flasks at a density of 2310 4 cells per cm 2 in Dulbecco modified Eagle medium (DMEM; PAA, Pasching, Austria), supplemented with 10% fetal calf serum (FCS; Biochrom, Berlin, Germany) and 1% penicillin/streptomycin (PAA, Pasching, Austria). After 72 h, nonadherent cells were carefully removed. Adherent cells were washed with phosphate-buffered saline (PBS) and were detached using 0.05% trypsin-ethylenediaminetetraacetic acid (trypsin-EDTA) and replated in fresh medium. Stem cell lines were established as described before. 11, [17] [18] [19] Clonality of the cell lines was achieved by immortalisation of the primary cells with simian virus 40 (SV40) large T antigen, followed by cellular cloning and subcloning. This method was used because it has been well established in our group. 11, [17] [18] [19] Flow cytometry After expansion, two strains (clones 5 and 7) were analysed by flow cytometry. A total of 0.5310 6 cells were pelleted and washed in PBS and resuspended in 100 mL of PBS/1% bovine serum albumin (BSA). The cell suspension was first incubated for 15 min at 4 6 C with 10% (V/ V) sheep serum and then for 30 min at 4 6 C with antibodies against rat CD markers or with corresponding isotype controls. Antibodies against rat CD29, CD49a, CD49b, CD49d, CD49e, CD54, CD61, CD90 and CD106 were purchased from BD Biosciences (San Jose, CA, USA), CD49d from Serotec (Raleigh, NC, USA) and CD45 and CD31 from Acris (Herford, Germany).
CD29, or beta-1 integrin, participates as a fibronectin receptor in cell adhesion. It has been regarded as a positive marker of MSCs. [20] [21] CD31 is platelet endothelial cell adhesion molecule 1. The absence of CD31 is a typical feature of MSCs.
22 CD45 (protein tyrosine phosphatase receptor type C or leukocyte common antigen) can be found on the surface of differentiated haematopoietic cells, and it plays an important role in signal transduction to T-and B-cell receptors; therefore, it has been used as negative selective marker. [23] [24] CD49a, or alpha-1 integrin, has been used to isolate MSCs from bone marrow. [25] [26] CD49b, or alpha-2 integrin, participates in collagen I binding and might play a role in the survival of MSCs on collagen I. 8 CD49d is the alpha-4 integrin subunit that is present in human MSCs under certain culture conditions. 27 CD49e, or alpha-5 integrin, participates in fibronectin and fibrinogen binding and is considered a typical MSC marker. [28] [29] CD54 (intercellular cell adhesion molecule-1, ICAM-1) is known to be responsible for MSC interaction in bone marrow stroma with hyaluronan, a major component of extracellular matrix. 30 CD61, or integrin beta-3, is believed to be negative in MSCs.
31 CD90 (thymocyte differentiation antigen-1,Thy-1) is a positive marker recommended by the International Society for Cellular Therapy position statement.
24 CD106 (vascular cell adhesion molecule 1, VCAM-1) is expressed on activated endothelial cells, and it facilitates adhesion of haematopoietic cells to endothelial cells and subsequently their migration into tissue. Typically, human bone marrow derived mesenchymal stem cells (BMSCs) express CD106. 21, 23 The cells were washed and resuspended in PBS containing sodium azide and BSA. Shortly before obtaining measurements, 20% (V/V) (7-amino-actinomycin D (7-AAD, 20 mg?mL 21 ) was added to each sample for 3 min to stain the dead cells, which were then excluded from the evaluation.
All of the measurements were obtained using a FACSCalibur flow cytometer, and the data were acquired using the CellQuest software (both BD Biosciences, San Jose, CA, USA). The measurements were evaluated with WinMDI software, version 2.8 (free access at http:// facs.scripps.edu/software.html). A minimum of 1310 4 viable cells of the population was acquired per data set.
The percentage of positive cells was determined as the percentage of cells having a measured fluorescence greater than that of 99.5% of the cells that were stained with each associated isotype control. A population was considered positive for a surface marker when the percentage of positive cells for that surface marker was o5%.
In vivo studies Unilateral ligation of the submandibular gland main excretory duct was performed as described by Turner et al. 32 Ethical approval was obtained from the Bavarian government (approval no: 209.1/211-2531-55/03). Briefly, 24 Wistar rats were anaesthetized by isofluorane inhalation. The experimental animals were positioned on their backs, and the skin of the neck was shaved and disinfected. A longitudinal incision was made in the midline of the neck, and both submandibular glands were exposed. Then, the main excretory duct was exposed under a microscope. At approximately 2 mm distant from the right gland, the duct was ligated twice with 8-0 silk. On the left side, we performed sham surgery with exposure of the duct only.
No ligation was applied on the left side; thus, it served as an internal control.
Subsequently, the skin was sutured with 5-0 Prolene, and the rats were allowed to recover. Approximately 5 h after the initial damage, 12 animals were i.v. injected in the tail vein with 1310 6 stem cells per 25 g of bodyweight. The cell concentration was 10310 6 cells per mL. Twelve animals received direct injections into the ligated glands under i.v. anaesthesia. For this purpose, the suture was re-opened, and the gland was exposed and visualized directly. The number of stem cells was the same as in the intravenous group: 1310 6 cells per 25 g of body weight. The cell concentration was again 10310 6 cells per mL. A 200 g rat was injected with 0.8 mL of cell suspension. The injection was placed in the macroscopic centre of the gland.
The animals were euthanized at days 1, 3 and 7. The salivary glands, liver, small intestine, lymph nodes, spleen and thymus were removed for further analyses. Six additional animals were injected intravenously with stem cells without any further manipulation.
Histology and immunohistochemistry
Samples were fixed in formaldehyde for 24 h and embedded in paraffin. Sections of 5 mm in thickness were obtained using a microtome.
Haematoxylin-eosin staining
Haematoxylin-eosin (HE) staining was performed to assess the morphological changes in the salivary gland tissue. The heat-fixated sections were deparaffinized and rehydrated. Subsequently, the sections were digested with 1% hyaluronidase (H3506-100MG, in PBS; Sigma, Steinheim, Germany ) for 20 min. Endogenous biotin was blocked using the Biotin-Blocking System (Dako, Clostrup, Denmark). Immunohistological staining was performed using the EnVision1System-HRP (DAB) (Dako, Clostrup, Denmark), according to manufacturer's instructions.
The primary antibodies were diluted (1:400), added to the sections and incubated for 1 h in a humidified box at room temperature. Counterstaining of the cell nuclei was performed with Mayer's haematoxylin for 30 s. We performed semiquantitative evaluation using the following ranges of cell numbers per section in 310 magnification: 0, no cell; 1, less than 10 cells; 11, 10-30 cells; 111, more than 30 cells.
RESULTS

Morphological and surface characteristics of rat stem cell lines
Two distinct clones (nos. 5 and 7) were analysed before in vivo application. Both clones consisted of adherently growing cells with a fibroblastoid morphology, which, upon appropriate stimulation, gave rise to adipocytes and osteoblasts in culture (data not shown). The cell surface phenotype was found to be comparable to the MSCs isolated from other sources. Immunophenotypically, the cell population was found to be positive for CD29, CD44, CD49e, CD54 and CD90 and negative for CD45, CD61, CD31, CD106 and CD49d (Table 1) .
Surgical duct ligation resulted in an inflammatory response accompanied by necrosis Following surgical duct ligation, the behaviour of the animals, as well as the uptake of diet and water, was unimpaired. There was distinct swelling of the ligated submandibular region visible on the outside on days 1 and 3 after the surgical procedure, which disappeared by day 7. There were no signs of local infection in any of the animals. HE staining revealed intercellular oedema starting on day 1, which was associated with an inflammatory reaction. Impairment of acinar cells was detectable from day 3 onwards. By day 7, there was a widespread necrosis with fibrous tissue formation (Figure 1) . The retrieved secondary lymphatic organs all had macroscopically normal sizes and morphology.
Distribution of MSCs after intravenous injections
Although the stem cells were resuspended thoroughly prior to injection, 2 of 12 of the i.v. injected animals died immediately, most likely due to pulmonary embolisms. The remaining animals, as well as the intraglandularly injected animals, tolerated the procedure well.
Stem cells were detected in each of the retrieved lymphatic organs, namely, the thymus, lymph nodes and Peyer's patches of the small intestine, as well as in the spleen starting on day 1 (Table 2 ). After 3 
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days, a marginal increase in stem cells in the spleen and Peyer's patch was observed (Figure 2 ). In contrast, there was a decrease in stem cell numbers in some of the lymphoid organs by day 7 (Table 2) , such as in the thymus and lymph nodes, while the spleen and Peyer's patch maintained the same levels as observed on day 3 ( Figure 2 ). Starting on day 1, stem cells were present in the salivary glands (Figure 3) . Neutrophils, leucocytes and macrophages were only occasionally present in any of the salivary gland specimens. The numbers of stem cells observed in the respective organs were comparable among the different animals.
Migration of stem cells into ligated and non-ligated salivary glands following intravenous injections
On day 1, stem cells were present in ligated salivary glands, infiltrating the periadrenal soft tissue (Figure 4a ). In non-ligated glands, MSCs ( Figure 4b) were present as well, and the number and distribution of the cells were comparable to those in the ligated glands. Leucocytes and macrophages were only present occasionally in both the ligated and the non-ligated glands. On day 3, diffuse distribution of the SV40-labelled cells was visualized within the ligated (Figure 4c ) and non-ligated glands (Figure 4d ). Some leucocytes and macrophages were present in a comparable manner. After 7 days, accumulations of MSCs were present in both the ligated and the non-ligated submandibular glands (Figure 4e and 4f) . Again, relatively few macrophages and leucocytes were detectable (Table 3) . Surprisingly, neutrophils were almost never detected in any of the specimens at any time point.
Stem cell and leucocyte distributions in ligated and non-ligated salivary glands following intraglandular injections
Due to the volume of the stem cell solution being equal to the intravenously injected volume (0.8 mL), significant oedema of the directly The frequency of MSCs in the ligated glands increased beyond the frequency of MSCs in the sham-operated side. Similarly, recruitment of leukocytes and macrophages to the ligated glands was enhanced ( Figure 6 ). These data suggest that MSCs were preferentially retained in the ligated glands and contributed to the subsequent recruitment of leucocytes to the sites of tissue injury. Mesenchymal
DISCUSSION
In this study, we were able to isolate and characterize two MSC lines from rat bone marrow. The cells were immortalized with the SV40 large T antigen and were cloned, as reported previously. 11, 33 Then, the cells were intravenously injected into a rat model of salivary gland damage, in which the damage was induced by ligation of the main submandibular duct, as described elsewhere. 32, 34 We demonstrated the recruitment of stem cells into the lymphatic organs and trafficking into ligated and non-ligated salivary glands.
MSC recruitment to the spleen, thymus, and lymph nodes in our rat model was comparable to homing, as we previously demonstrated in a mouse model using human cells. 33 The constitutive expression of the CCR7 ligands CCL21 and CCL19 in lymphatic tissue and the functional expression of CCR7 and CXCR5 33 have been suggested to play roles in the recruitment of MSCs to lymphatic organs. [35] [36] [37] The injected cells were found as single cells or as clusters throughout the examined organs. The relatively large numbers of injected cells detected in the spleen might have been due in part to trapping by the reticuloendothelial system. 33 The current observations suggest that there was profound homeostatic/non-inflammatory traffic of MSCs into the salivary glands, which was not significantly enhanced by ligation, at least under the experimental conditions used in this model. This observed traffic was relatively rapid and could already be detected on day 1, and it did not significantly increase until day 7. Earlier time points, e.g., less than 24 h, were not investigated.
Ligation of the salivary gland can be considered a process of sterile tissue damage. Cell death associated with sterile damage normally induces inflammation and the influx of inflammatory leucocytes.
38 Surprisingly, however, there was only a slight influx of leucocytes and macrophages in our model, despite ligation of the submandibular duct. This finding indicated that ligation of the duct induced relatively minor trauma only, although induction of interleukin 6, tumour necrosis factor alpha-b and interleukin 1b were recently demonstrated at the RNA level. 39 Leucocytes and macrophages were also detected in untreated salivary glands after i.v. injections of stem cells. However, their presence was clearly enhanced after intraglandular injection of MSCs into ligated glands.
These findings raise the question of why there was such a difference between intravenous MSC and intraglandular MSC injections with regard to subsequent recruitment of CD45-and CD68-positive cells. Based on our findings, we hypothesize that ligation plus the additional trauma caused by direct intraglandular injection could result in enhanced retention and subsequent recruitment of immune cells. This enhanced retention would result in an increased influx of leucocytes. This hypothesis is consistent with our previous investigations, which demonstrated that MSCs activated and interacted with inflammatory cells. 40 Furthermore, there has been convincing experimental evidence that MSCs recruited monocytes and macrophages. 41 Neutrophils are mostly involved in antimicrobial responses, and they strongly respond to bacterial stimulation. Accordingly, we recently showed that MSCs from human parotid glands, which were exposed to bacterial lipopolysaccharide, 40 attracted neutrophils in vitro. In our model of salivary gland damage, only minor sterile inflammation seemed to be induced. Injection of MSCs into this area of mild sterile inflammation resulted in a substantial influx of leucocytes, which was, however, not dominated by neutrophils. This outcome supports recent findings describing a modification of local immune response with absence of neutrophils in vivo. 42 We previously demonstrated that the injection of a mesenchymal CD34 2 adult stem cell line showed significant improvement in tissue perfusion in mice with chronic ischaemia. 11 The mobilisation of stem cells from the bone marrow by granulocyte colony-stimulating factor has been proposed as a similar strategy for repairing infarcted myocardium, as well as salivary gland damage due to radiation therapy. While in the myocardium, the improvement in cardiac function seemed to be a direct effect of granulocyte colony-stimulating factor, rather than induced by the mobilisation of stem cells, [43] [44] in the salivary glands, MSCs mobilized from the bone marrow seemed to contribute directly to the improvements in tissue function and morphology by local cytokine-mediated interactions with the tissue stem cells. 45 However, the exact mechanism of this improvement has not been clarified completely. Tran and coworkers 15 postulated that improved salivary gland function resulted from a combination of various mechanisms, such as cell fusion, transdifferentiation, vasculogenesis and paracrine signalling. Importantly, no chemotactic or mobilizing agents were used in the current study, the use of which has often given rise to various side effects and toxicities.
Three other studies have used intraglandular administration of stem cells to date. Kojima and co-workers 14 used a mouse model, in which they induced salivary gland damage by irradiation with 10 Gy. They used a much smaller number of adipose-derived stem cells (5310 5 ) compared to our study, in which we applied 8310 6 cells in rats. Nevertheless, they were able to demonstrate an increase in salivary flow. Lin and co-workers 46 used 1310 6 stem cells in a 15 Gy irradiated mouse model, and they were also able to demonstrate increased salivary flow rates in irradiated animals. Lim and co-workers 47 only recently published similar results, confirming the potential of bone marrow-derived stem cells for direct intraglandular injections. Tran and co-workers 48 aimed to analyse the possible paracrine effects of bone marrow-derived MSCs by injecting so-called 'bone marrow soup', i.e., the intracellular contents of bone marrow-derived stem cells, intraglandularly and intravenously. In fact, they were able to demonstrate that the intracellular contents themselves were as beneficial as the intravenous injection of viable stem cells.
Interestingly, none of these studies investigated whether MSCs migrated to the salivary glands also, in the absence of radiation damage. von Lüttichau 33 observed the migration of bone marrowderived stem cells into the salivary glands, which was hypothesized to be based on the chemokine receptor profiles of these cells (CCR 4 and CCR10) and their corresponding chemokine expressions in the salivary glands. Therefore, their study, as well as our current study, demonstrated stem cell trafficking into the salivary glands under physiologic conditions (our sham-operated sides and our untreated group). These findings resulted in the conclusion that basic trafficking of MSCs from the bone marrow into the salivary glands occurred under physiological conditions. This conclusion might explain the observations of Tran and co-workers, 49 who found Y chromosomeexpressing cells in the salivary glands of female patients who had been transplanted with bone marrow from male donors.
Based on the surgical model used, in which the submandibular duct was ligated without removal of the ligation, regeneration was not obtained, and it was not an aim of this study. Therefore, the function of stem cells in the salivary glands could not be assessed. Additionally, the volume of the stem cell suspension used in the study was relatively large. As a consequence, we hypothesize that additional trauma was applied to the salivary tissue structures, thus rendering a direct comparison of both methods of administration more complicated.
CONCLUSIONS
In conclusion, our data indicated that immortalised stem cells were a useful tool for studying the in vivo fate of MSCs during cellular therapy. Profound homeostatic/non-inflammatory traffic to the salivary Mesenchymal stem cells migrate to salivary glands S Schwarz et al 160 glands and retention of intraglandularly injected MSCs were observed. These findings could contribute to a greater understanding of the interactions between MSCs and inflammatory cells in future cellular MSC therapies.
